-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
- Beam Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $5.46 M, a 121% increase year-over-year.
- Beam Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $48.3 M, a 34.5% decline year-over-year.
- Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $45.3 M, a 42.1% decline from 2022.
- Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $78.3 M, a 259% increase from 2021.
- Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $21.8 M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)